Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer
Authors:
- 11 December 2012
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 34 (2) , 821-825
Abstract
The aim of this study was to detect MAC30 expression in human non-small cell lung cancer (NSCLC) and to analyze its association with prognosis of NSCLC patients. Quantitative real-time RT-PCR was performed to examine the expression of MAC30 mRNA in 20 cases of NSCLC and corresponding non-tumor tissue samples. Immunohistochemistry was performed to detect the expression of MAC30 in 95 NSCLC tissues. We found that the expression levels of MAC30 mRNA in NSCLC tissues were significantly higher than those in corresponding non-tumor tissues. High-level MAC30 expression was correlated with poor tumor differentiation, TNM stage, and lymph node metastasis. Patients with high expression levels of MAC30 showed lower overall survival rate than those with low expression levels. Multivariate analysis showed that high MAC30 protein expression was an independent prognostic factor for NSCLC patients. Our study suggests that over-expression of MAC30 may play an important role in the progression of NSCLC and MAC30 expression may offer a valuable marker for predicting the outcome of patients with NSCLC.Keywords
This publication has 15 references indexed in Scilit:
- Significance of mRNA and Protein Expression of MAC30 in Progression of Colorectal CancerChemotherapy, 2011
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Expression of MAC30 in Rectal Cancers with or without Preoperative RadiotherapyOncology, 2006
- Non-Hodgkin lymphoma: an updateThe Lancet Oncology, 2004
- Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression.2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001
- Identification of differentially expressed mRNAs in human fetal liver across gestationNucleic Acids Research, 1999
- TNM classification of malignant tumors, fifth edition (1997)Cancer, 1997
- Identification and characterization of genes differentially expressed in meningiomas.1993